Why Theatre Audiences Are Filling Seats But Shows Still Lose Money

While millions of Australians continue to buy tickets, mounting venue expenses, labour overheads, and the inherent limits of theatrical productivity are pushing major companies into deep financial deficits.

Why Rising Box Office Revenue Is Not Enough to Save Theatre Companies

According to financial statements reviewed for 2024 and 2025, major Australian theatre companies are struggling to break even despite drawing larger audiences. Queensland Theatre grew its mainstage audience by 5.6 per cent in 2025 and boosted box-office revenue by 42 per cent compared to the previous year, yet the company recorded a $989,000 deficit, as noted in its financial filings.

Similarly, Bell Shakespeare saw its income climb from $10.96 million to $11.47 million, but expenses outpaced that growth by jumping from $10.99 million to $12.87 million. Meanwhile, Sydney Theatre Company generated $28.75 million in revenue from continuing operations in 2025, only to post an underlying operational deficit of $8.76 million before one-off funding and fundraising pulled the bottom line into a modest $786,418 surplus.

Did You Know? According to the Australian Bureau of Statistics’ 2025 General Social Survey, 22.8 per cent of Australians aged 15 and over—representing more than 5 million people—attended a theatre performance in the 12 months prior to the study.

The Hidden Costs of Production and the Reality of Baumol’s Cost Disease

Running a professional stage production involves massive overheads long before opening night. Theatre producer Suzanne Jones stated that the latest Australian production of The Book of Mormon cost $11.5 million just to reach its opening night. Beyond venue hire, sets, transport, marketing, and insurance, labour costs remain rigidly high due to minimum wage standards.

Based on minimum wage conditions outlined in the Media Entertainment & Arts Alliance’s (MEAA) Performers’ Collective Agreement 2026, employing a rare cast of 11 actors for a four-week rehearsal period and a four-week season costs at least $154,400 for performers alone—excluding directors, stage managers, designers, and crew. This dynamic reflects the economic concept identified by economists William Baumol and William Bowen in 1966, known as “cost disease.” While manufacturing sectors leverage technology and automation to boost productivity, live theatre cannot automate its human performers without fundamentally changing the art form.

Pro Tip: Independent and smaller theatre companies are increasingly turning to streamlined scripts, smaller casts, and innovative staging—such as solo performances like Sydney Theatre Company’s An Iliad—to manage operational costs without sacrificing artistic integrity.

Industry Proposals: Tax Relief and Cultural Passes

To combat these structural economic challenges, the Australian theatre industry is calling on the federal government for a live performance incentive modelled on the United Kingdom’s theatre tax-relief scheme, which allows UK companies to claim close to 50 per cent in tax deductions. Because many Australian theatre companies operate as charities or not-for-profits with minimal taxable profit, industry advocates suggest a refundable theatre production incentive similar to the 30–40 per cent offsets currently provided for eligible screen production expenditure.

Additionally, the MEAA has proposed a government-funded cultural pass worth up to $200 for young people to stimulate attendance. Producers emphasize that a combination of public funding, targeted tax incentives, philanthropy—such as Queensland Theatre’s Scene Project (funded by the Rekindle Foundation), which reached almost 4,000 students in 2025—and balanced ticket pricing will be required to keep the local stage alive.

Frequently Asked Questions

Why are major Australian musicals being cancelled?

Major productions face mounting financial pressure as operational expenses—including wages, venue hire, and materials—outpace revenue growth, driven by what economists call Baumol’s cost disease.

What is Baumol’s cost disease in theatre?

Identified by economists William Baumol and William Bowen in 1966, it describes how live theatre cannot use automation to increase labour productivity like other industries without altering the artistic product itself.

Are theatre audience numbers dropping in Australia?

Not necessarily. The Australian Bureau of Statistics’ 2025 General Social Survey showed that 22.8 per cent of Australians aged 15 and over attended a theatre performance in the prior 12 months, representing more than 5 million attendees.

What solutions are industry groups proposing?

The industry is lobbying for a refundable government production incentive modelled on screen production offsets, alongside youth cultural passes and continued philanthropic and public funding support.

Join the Conversation

What are your thoughts on the financial pressures facing the Australian theatre industry? Share your perspective in the comments below, explore our related coverage on the arts economy, or subscribe to our newsletter for weekly updates.

✨ How To Fill Your Theatre Seats | Magic In Motion Stage Show

Leave a Comment